These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36975491)

  • 21. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
    Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
    Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PMab-235: A monoclonal antibody for immunohistochemical analysis against goat podoplanin.
    Furusawa Y; Yamada S; Nakamura T; Sano M; Sayama Y; Itai S; Takei J; Harada H; Fukui M; Kaneko MK; Kato Y
    Heliyon; 2019 Jul; 5(7):e02063. PubMed ID: 31338471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a Monoclonal Antibody PMab-295 Against Elephant Podoplanin.
    Kudo Y; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Aug; 41(4):194-201. PubMed ID: 35917562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct CD44 splice variants differentially affect collateral artery growth.
    Bot PT; Grundmann S; van Royen N; Joosten SP; Schirmer SH; de Kleijn DP; Pals ST; Pasterkamp G; Piek JJ; Hoefer IE
    Curr Vasc Pharmacol; 2013 Jan; 11(1):13-20. PubMed ID: 23391418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
    Bourguignon LY; Gunja-Smith Z; Iida N; Zhu HB; Young LJ; Muller WJ; Cardiff RD
    J Cell Physiol; 1998 Jul; 176(1):206-15. PubMed ID: 9618160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.
    Afify A; Pang L; Howell L
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):446-50. PubMed ID: 18091389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers.
    Nanamiya R; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2023 Oct; 42(5):166-177. PubMed ID: 37824755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a Sensitive Anti-Mouse CD39 Monoclonal Antibody (C
    Okada Y; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2024 Feb; 43(1):24-31. PubMed ID: 38197855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitigation of delayed-type hypersensitivity reactions by a CD44 variant isoform v3-specific antibody: blockade of leukocyte egress.
    Seiter S; Engel P; Föhr N; Zöller M
    J Invest Dermatol; 1999 Jul; 113(1):11-21. PubMed ID: 10417612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
    Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
    Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of EMab-134, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Detecting Squamous Cell Carcinoma Cells of the Oral Cavity.
    Itai S; Yamada S; Kaneko MK; Chang YW; Harada H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):272-281. PubMed ID: 29090976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression.
    Franzmann EJ; Weed DT; Civantos FJ; Goodwin WJ; Bourguignon LY
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):426-32. PubMed ID: 11283501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
    Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S
    Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression.
    Zhu H; Zhou W; Wan Y; Lu J; Ge K; Jia C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of CD44 isoforms in normal human liver and also in regenerative and neoplastic liver changes].
    Seelentag WK; Flury R; Schmid M; Komminoth P; Saremaslani P; Günthert U; Heitz PU; Roth J
    Verh Dtsch Ges Pathol; 1995; 79():144-7. PubMed ID: 8600679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an anti-bear podoplanin monoclonal antibody PMab-247 for immunohistochemical analysis.
    Furusawa Y; Takei J; Sayama Y; Yamada S; Kaneko MK; Kato Y
    Biochem Biophys Rep; 2019 Jul; 18():100644. PubMed ID: 31061899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
    Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
    J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
    Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
    Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44 loss in gastric stromal tumors as a prognostic marker.
    Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
    Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of an Anticetacean Podoplanin Monoclonal Antibody PMab-237 for Immunohistochemical Analysis.
    Kato Y; Furusawa Y; Itai S; Takei J; Nakamura T; Sano M; Harada H; Yamada S; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2019 Jun; 38(3):108-113. PubMed ID: 31161965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.